TickerFacts.

Compare

NeoGenomics Inc vs UL Solutions Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNeoGenomics Inc
NEO		UL Solutions Inc.
ULS
Year ended2025-12-312025-12-31
Revenue$727.33M$3.05B
Revenue growth (YoY)+10.1%+6.4%
Gross margin43.2%49.5% (computed)
Operating margin-15.9%17.1%
Net margin-14.9%10.6%
Net income-$108.03M$325.00M
EPS (Diluted)n/a$1.60
Operating cash flow$5.23M$600.00M
Free cash flow-$21.78M$403.00M
Cash & equivalents$159.62M$295.00M
Total assets$1.36B$2.92B
Total liabilities$523.27M$1.63B
Shareholders' equity$836.56M$1.29B
Return on year-end equity-12.9%25.1%
Shares outstanding128.15M201.03M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNeoGenomics IncUL Solutions Inc.
Latest$727.33M
Ended 2025-12-31		$3.05B
Ended 2025-12-31
1 year earlier$660.57M
Ended 2024-12-31		$2.87B
Ended 2024-12-31
2 years earlier$591.64M
Ended 2023-12-31		$2.68B
Ended 2023-12-31
3 years earlier$509.73M
Ended 2022-12-31		$2.52B
Ended 2022-12-31
4 years earlier$484.33M
Ended 2021-12-31		n/a